Gefitinib Stada

Gefitinib Stada is an oral medication used to treat certain types of cancer. This pharmaceutical is designed to target specific proteins involved in cancer cell growth.

Gefitinib Stada is primarily used in the treatment of non-small cell lung cancer (NSCLC) that has spread or cannot be removed by surgery. It works by targeting and inhibiting the epidermal growth factor receptor (EGFR), which can help slow the growth and spread of cancer cells. This medication is often prescribed for patients with specific mutations in the EGFR gene.

Common effects of Gefitinib Stada may include skin rash, diarrhea, and dry skin. Some users may also experience nausea, vomiting, or appetite loss. It is important to consult a healthcare provider if any of these effects become severe or persistent.

Gefitinib Stada should be handled with care and stored as directed. It is important to inform your healthcare provider about any other medications you are taking to avoid potential interactions. Pregnant women or those planning to become pregnant should discuss the risks and benefits with their doctor.

Gefitinib Stada may interact with certain medications, including those that are metabolized by the liver's cytochrome P450 enzymes. It is also important to avoid grapefruit and grapefruit juice, as they can affect the metabolism of this medication. Always consult a healthcare provider before starting or stopping any medication.